Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Atopic Dermatitis”

390 trials

Showing 20 of 390 results

Post-approval studies (Phase 4)Study completedNCT05507580
What this trial is testing

Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 461
Testing effectiveness (Phase 2)Looking for participantsNCT07297602
What this trial is testing

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Who this might be right for
Atopic Dermatitis
Nora Mohamed Abdelrazik 36
Large-scale testing (Phase 3)Study completedNCT01500941
What this trial is testing

Probiotics in Adults: do They Improve Atopic Dermatitis?

Who this might be right for
Adult Atopic Dermatitis
ASST Fatebenefratelli Sacco 48
Early research (Phase 1)Ended earlyNCT05177328
What this trial is testing

Targeted Investigation of Microbiome Elimination

Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 21
Large-scale testing (Phase 3)Study completedNCT04417894
What this trial is testing

Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Who this might be right for
Moderate to Severe Atopic Hand and Foot Dermatitis
Regeneron Pharmaceuticals 133
Early research (Phase 1)Study completedNCT04100642
What this trial is testing

A Phase I Clinical Study of Hemay808

Who this might be right for
Safety Issues
Tianjin Hemay Pharmaceutical Co., Ltd 42
Testing effectiveness (Phase 2)Study completedNCT02525094
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 113
Early research (Phase 1)Study completedNCT05114889
What this trial is testing

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Biosion, Inc. 54
Large-scale testing (Phase 3)Study completedNCT05149313
What this trial is testing

Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

Who this might be right for
Dermatitis, AtopicEczema
Almirall, S.A. 331
Testing effectiveness (Phase 2)Ended earlyNCT05984784
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic DermatitisAD
Inmagene LLC 13
Early research (Phase 1)Looking for participantsNCT07239947
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 63
Not applicableStudy completedNCT03632174
What this trial is testing

Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
BioGaia AB 36
Not applicableWithdrawnNCT05545215
What this trial is testing

Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
Pierre Fabre Medicament
Not applicableStudy completedNCT04553224
What this trial is testing

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 17
Large-scale testing (Phase 3)WithdrawnNCT05233410
What this trial is testing

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Who this might be right for
Chronic Hand Eczema (CHE)
Incyte Corporation
Not applicableStudy completedNCT05451316
What this trial is testing

Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

Who this might be right for
Atopic Dermatitis
AbbVie 1
Large-scale testing (Phase 3)Study completedNCT02755649
What this trial is testing

Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 325
Early research (Phase 1)Study completedNCT06974292
What this trial is testing

The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 6
Testing effectiveness (Phase 2)Study completedNCT01407510
What this trial is testing

HPA Axis Study in Japanese Adults

Who this might be right for
Atopic DermatitisEczema
Bayer 12
Large-scale testing (Phase 3)Study completedNCT06238817
What this trial is testing

Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 241
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation